CCO Infectious Disease Podcast

Key HIV Studies Influencing My Practice Following IDWeek 2021 – Audio Recap

Episode Summary

Listen to expert insights from Darcy Wooten, MD, on updates and new HIV data from IDWeek 2021, including 2-drug ART, metabolic outcomes, investigational agents, and survey data of the U=U educational campaign.

Episode Notes

In this episode, Darcy Wooten, MD, discusses new HIV data from IDWeek 2021, including:

• A rapid test-and-treat program to start DTG/3TC in patients newly diagnosed with HIV (STAT)
• Efficacy when switching from 3-drug to 4-drug TAF-based regimens to DTG/3TC (TANGO)
• Virologic outcomes with 2-drug vs 3-drug ART regimens (Trio Health HIV Network Study)
• Metabolic complications in treatment-naive patients (Study 1489 and Study 1490)
• Resistance analysis of an investigational agent, lenacapavir (CALIBRATE)
• The Positive Perspectives Survey to evaluate the U=U Educational Campaign in North American patients

Presenter:

Darcy Wooten, MD
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California

Link to full program:
https://bit.ly/3BCHF2E